News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Serena Jenkins, PhD

Articles by Serena Jenkins, PhD

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Telling Humanity’s Brain Story: Insights From Brain Capital

ByHarris A. Eyre, MD, PhD,Robert M. Lundin, BSc, MBBCh,Shuo Chen, JD,Ryan Abbott, MD, JD, PhD,Shekhar Saxena, MD,Stephen T. C. Wong, PhD,James T. Hackett,William Hynes, DPhil,Daniela Schiller, PhD,Nancy Mannix, JD,Serena Jenkins, PhD,Claire Neihaus, MSc,Walter D. Dawson, DPhil,Michael Berk, MD, PhD

January 19th 2023

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Latest Updated Articles

Telling Humanity’s Brain Story: Insights From Brain Capital
Published: January 19th 2023 | Updated:

Trending on Psychiatric Times

Whatever Happened to Psychopathology?

Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD

How Can Chatbots Be Made Safe for Psychiatric Patients

Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD

Who Should Avoid Halloween Tricks and Treats?

© 2025 MJH Life Sciences^®

All rights reserved.